JLC-112509 TOPONECHOICE Transcranial Magnetic Stimulation

Review TOPONECHOICE Transcranial Magnetic Stimulation For Parkinsons Disease Global Ischemia

The JLC-112509 Transcranial Magnetic Stimulation (TMS) system from NeuroStar is a state-of-the-art, non-invasive medical device designed for the treatment of Parkinson's Disease (PD) with global ischemia. This advanced technology is based on the principles of magnetic field induction to stimulate specific areas of the brain, helping to alleviate symptoms associated with PD.

The TMS system consists of a portable, ergonomically designed unit that delivers precise magnetic stimuli through an insulated coil. The therapy is administered while the patient is seated comfortably, with the treatment area being the left motor cortex. The system's built-in navigation technology ensures accurate and consistent placement of the coil for each treatment session.

The JLC-112509 TMS system utilizes a unique, high-frequency repetitive TMS (rTMS) protocol, specifically designed for PD patients with global ischemia. rTMS involves delivering rapid, brief magnetic pulses to the targeted brain region, with each pulse lasting approximately 1 millisecond. This protocol aims to help improve motor function and minimize unwanted side effects.

The system offers several advanced features to enhance the therapeutic experience for patients, including adjustable stimulation intensity and duration, as well as built-in safety mechanisms that monitor the patient's heart rate, blood pressure, and other vital signs during treatment. The treatment sessions are typically administered five days a week for six weeks, with each session lasting approximately 30 minutes.

The JLC-112509 TMS system from NeuroStar is a FDA-cleared medical device, signifying its safety and efficacy for the treatment of PD with global ischemia. The therapy is non-invasive, meaning it does not require surgery or anesthesia, and it carries a lower risk of side effects compared to traditional deep brain stimulation techniques. This makes it an attractive option for many PD patients seeking relief from their symptoms.

In summary, the JLC-112509 Transcranial Magnetic Stimulation system from NeuroStar is a cutting-edge, non-invasive medical device designed for the treatment of Parkinson's Disease with global ischemia. The system utilizes advanced technology and a unique, high-frequency repetitive TMS protocol to help improve motor function and minimize unwanted side effects. Its portable design, adjustable settings, and built-in safety features make it a safe and effective option for PD patients seeking relief from their symptoms.

Transcranial Magnetic Stimulation (TMS) is a non-invasive neurostimulation technique that has shown promise in the treatment of various neurological conditions, including Parkinson's Disease (PD). One specific TMS device that has gained attention in the PD community is the JHC-112509 from Global Medical Instruments. In this response, we will discuss the potential benefits and drawbacks of using this TMS device for the treatment of PD caused by global ischemia.

1. Non-Invasive: TMS does not require surgery, making it a less invasive option compared to deep brain stimulation (DBS), which is a more common treatment for PD.

2. Portable: The JHC-112509 is a portable device, which allows for greater flexibility in treatment locations.

3. Cost-Effective: TMS is generally less expensive than DBS, and the JHC-112509 is a more affordable option compared to other TMS devices.

4. Potential for Improved Motor Symptoms: Studies have shown that TMS can help improve motor symptoms in PD patients, including tremors, rigidity, and bradykinesia.

5. Targeted Stimulation: TMS allows for targeted stimulation of specific brain areas, which can help improve motor function and reduce symptoms in PD patients with global ischemia.

1. Limited Evidence: While some studies have shown positive results with TMS for PD, more research is needed to fully understand its effectiveness and long-term benefits.

2. Potential Side Effects: TMS can cause side effects such as headaches, scalp discomfort, and seizures in some cases.

3. Requires Expertise: Proper administration of TMS requires specialized training and expertise, which may not be readily available in all healthcare settings.

4. Limited Coverage: TMS, including the JHC-112509, may not be covered by insurance, making it an out-of-pocket expense for some patients.

5. May Not Be Effective for All Patients: TMS may not be effective for all PD patients, especially those with advanced disease or severe motor symptoms.

In conclusion, the JHC-112509 TMS device from Global Medical Instruments offers several potential benefits for the treatment of PD caused by global ischemia, including its non-invasive nature, portability, cost-effectiveness, and potential for improving motor symptoms. However, it also comes with some drawbacks, such as limited evidence, potential side effects, the need for expertise, and limited insurance coverage.

Based on the available evidence, TMS, including the JHC-112509, can be a viable alternative to more invasive treatments like DBS for some PD patients with global ischemia. However, it is important for patients to consult with their healthcare providers to determine if TMS is the right treatment option for their specific condition and to discuss any potential risks or benefits. Ultimately, more research is needed to fully understand the effectiveness and long-term implications of TMS for PD.

Therefore, I would recommend that patients with PD caused by global ischemia discuss the potential benefits and drawbacks of TMS, including the JHC-112509, with their healthcare providers to determine if it is a suitable treatment option for their individual situation. Additionally, they should consider participating in clinical trials or research studies to help advance the understanding and application of TMS for PD.

Details:

Multi-functions of RMS therapy transcranial magnetic treatment has 8 fixed frequency modes: 1/5/10/15/20/30/40/50hz, adjustable; trans magnetic stimulation therapy 11 conversion modes to choose from; field strength transcranial can be optional: strong 11mt-19mt, weak 6mt-10mt ; shock, no shock optional; time: 0-95 minutes, adjustable. Parkinsons disease ; 3, alleviate psychiatric diseases, such as depression, anxiety; 4, relieve chronic neuropathic pain; 5, improve amyotrophic lateral sclerosis, multiple sclerosis; 6, disorders of consciousness package details of Tm's therapy treatment safe and effective. Application of transcranial magnetic stimulation therapy RMS treatment is a painless, non-invasive, and no side effect method.

1, trans magnetic stimulation can treat alzheimer stroke disease; 2, treat motor diseases principle of Tm's treatment transcranial magnetic stimulation outputs specific regular alternating electromagnetic field to act on brain cells and cerebral blood vessels in order change the metabolic environment lesion area, so that enzyme activity involved metabolism is increased. Insomnia, parkinsons disease, paralysis, brain atrophy, schizophrenia, depression, anxiety, hyperactivity disorder, neurasthenia, stroke, autism, delusions, cerebral infarction. Transcranial magnetic stimulation Tm's treatment post traumatic stress disorder .

Tm's demonstrates diagnostic and therapeutic potential in the centurions system, can be used to treat various disease states Fields of neurology and mental health. The transcranial magnetic brain stimulation is recommend 20-30min each time, 5 times a week, continuously for 6-8 weeks or more. Principle -transcranial magnetic stimulation is a non-invasive form of brain that uses changing Fields to induce electrical currents in specific areas the through electromagnetic induction. Magnetic has the characteristics of light weight, small volume, applicable to people with different head circumference and comfortable wear.

Default us plug. Vegetative state or minimally conscious.

specifications magtherapydev:

• brand: Toponechoice
• mpn: Jlc-112509
• main purpose: Brain Stroke Dementia, Alzheimers Disease Ad, Parkinson, Disorders Of Consciousness, Stroke, Migraine, Autism, Chronic Neuropathic Pain, Motor Disease, Psychiatric Disease, Amyotrophic Lateral Sclerosis
• variable frequency modes: 11 Modes To Choose
• magnetic field frequency: 1/5/10/15/20/30/40/50hz, 8 Fixed Frequency Adjustable
• color: White Black
• working voltage: Ac 110v-240v, 50hz/60hz
• material: Abs
• time: 0-95 Minutes, Every 5 Minutes Adjustable
• head vibration mde: Available
• weak level magnetic strength: 6mt-10mt
• type: Stimulation Device
• department: Men, Unisex, Women
• unit type: Unit
• number of therapeutic heads: 1 Large Therapeutic Head 8 Small Therapeutic Head
• manufacturer warranty: 1 Year
• body area: Head
• features: Adjustable
• strong level magnetic strength: 11mt-19mt
• net weight: 1kg/2.21 Lbs
• country of origin: China

general magtherapydev:

• category: Health & Beauty > Natural Alternative Remedies > Magnetic Therapy

returns magtherapydev:

• paid by: buyer
• time: 30 days
• method: money back
• policy: returns accepted

payments magtherapydev:

• wallet: google-pay
• other
• credit card: mastercard

shipping magtherapydev:

• transit: 5-10 days
• service: standard
• class: standard
• type: fixed

seller magtherapydev:

• rating: 100.0%
• city: florence, kentucky
• # reviews: 34

offer magtherapydev:

• options: ship-to-home
• availability: in stock
• started: november 25, 2025
• best offers: true
• quantity: 1
• sold #: 15